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level of disturbance. A partial correlation, however,
holding age constant, increased the correlation between
lead level and the behaviour rating from 0029 to only
0’031 (still well below a statistically significant level).
The level of disturbance shown in this sample was high
but not " astoundingly " so to anyone acquainted with
comparable surveys carried out in London. Indeed, the
incidence of disturbance among the children in our sample
with blood-lead levels of 40 &micro;g. and above was strikingly
similar to that found in another London borough-18-6%
compared with 19-1%.’ The fact that the children in our
sample with blood-lead levels below 40 jjtg. were more
disturbed than the others did not make us think that a
high lead level is associated with normal behaviour; it
did indicate that factors other than lead ingestion should
be considered. We did not imply that there was a difference
in social class between the families who had recently
moved into the area and those who had been living there
since their children were very young; we noted the
differences in behaviour and intelligence and reported
anecdotal evidence that there were differences other than
those crudely measured by the Registrar-General’s classi-
fication. We agree though that a further analysis of family
factors would have been desirable.
We see no reason to reconsider our main conclusion
at this stage. In our view it is just not possible to in-
criminate lead as a cause for the clinical manifestations
described in the lengthy quotation cited by Bryce-Smith
and Waldron in the absence of clear evidence of lead
encephalopathy. Confident assertions to the contrary
can only be sustained if the evidence supporting them is
based on studies which are methodologically sound. The
reasons for regarding social factors (both extra-familial
and intra-familial) as important in the causation of behaviour
disorders in city children do not, of course, lie merely in
our own anecdotal evidence, but in a number of other
excellent studies beyond the scope of the present discussion.







CONGENITAL HEART DEFECTS AND
PRENATAL SEX HORMONES
’ 
SIR,&mdash;Two retrospective case-control studies have
suggested an association between prenatal use of sex
hormones and subsequent congenital heart-disease,
especially transposition of the great vessels (T.G.V.).8,9
We examined this possible association by identifying 88
patients with T.G.V. who were less than 5 years old when first
seen in the Children’s Cardiac Center, Johns Hopkins
Hospital, from January, 1968, to April, 1973. In obtaining
the cases from a computer index of all patients, we included
embryological variations of conal defects, such as single
ventricle and corrected transposition. Demographic data
were abstracted as well as information on the history and
outcome of pregnancy, including birth defects. In taking
the medical history, various clinicians had used a standard
questionary that included specific questions on hormones
and other drugs, but the responses were not independently
verified. As controls, charts of patients with only ventricu-
lar septal defects (v.s.D.) and with normal hearts (usually
functional murmurs) were chosen and matched for sex
and race, and as closely as possible for year and age at first
visit.
The 3 groups of patients each had 58 males (50 White,
8 Black) and 30 females (22 White, 8 Black). Of the patients
7. Rutter, M. L. Proc. R. Soc. Med. 1973, 66, 1221.
8. Levy, E. P., Cohen, A., Fraser, F. C. Lancet, 1973, i, 611.
9. Nora, J. J., Nora, A. H. ibid. p. 941.
with conotruncal defects (63 T.G.V., 19 single ventricle, and
6 corrected transposition), 4 cases, all with T.G.v., had
prenatal exposure to sex hormones during the first trimester
(2 for maintenance of pregnancy, 1 for inadvertent birth
control, and 1 for fertility). 2 of the 4 also had congenital
idiopathic microcephaly and mental deficiency, but
shared no other dysmorphic features.
Among controls, 3 with V.S.D. and 3 with normal hearts
were exposed to prenatal sex hormone during the first
trimester. In addition, in 2 with V.S.D., time of exposure
was not specified and, in 1 normal control, was in the last
2 trimesters only. 1 of the V.S.D. patients had microcephaly,
another had pectus excavatum; no birth defects were re-
corded among the normal controls. Hormones were given
to the controls (a) to maintain pregnancy (5 cases); (b) as
birth control (1 case); and (c) for unclear reasons (3 cases).
These results, obtained retrospectively, fail to support
the suggested association between transposition complexes
and prenatal exposure to sex hormone. Rather, they point











METABOLIC AND HORMONAL RESPONSE TO
ACUTE MYOCARDIAL INFARCTION
SiR,&mdash;Dr Vetter and others (Feb. 23, p. 284) have made
it difficult to evaluate the full significance of their findings
on the initial metabolic and hormonal changes after acute
myocardial infarction by the lack of matched controls. The
rituals of admission to a hospital have been shown to
significantly increase urinary 17-hydroxycorticosteroids in
healthy adults.1 To state that individuals after admission
to a modern coronary-care unit for suspected myocardial
infarction have elevated plasma-cortisol, catecholamines,
sugar, and free fatty acids might be saying little more than
that the patients are undergoing severe psychological stress.
Before any statements can be made from this study regard-
ing the systemic response to acute myocardial infarction,
might it not be helpful to study control levels from patients
who underwent a similar ordeal, but did not have a
detectable infarct ?
University of Michigan Medical School,
Ann Arbor, Michigan 48104, U.S.A. LEONARD A. PALLOR.
* * * We showed this letter to Dr Vetter and his colleagues,
whose reply follows.-ED. L.
SiR,&mdash;Your correspondent makes a legitimate point of
which we are, of course, aware. But who shall be the
controls ? One has to identify a group of individuals,
apparently well and going about their usual work, who are
suddenly and unexpectedly confronted with a crisis
associated with severe pain and are then admitted to an
intensive-care unit within an hour. Probably the only
comparable groups are patients with burns or trauma, and
in both situations 2,3 the metabolic responses are compar-
able to those described by us in patients with myocardial
infarction. Patients with acute myocardial isch&aelig;mia will
not do as controls, since their initial metabolic response is
likely to be similar to those with myocardial infarction.
1. Mason, J. W., Sachar, E. J., Fishman, J. R., Hamburg, D. A.,
Handlon, J. H. Archs gen. Psychiat. 1965, 13, 1.
2. Birke, G., Carlson, L. A., Liljedahl, S.-O. Acta med. scand. 1965,
178, 337.
3. Johnston, I. D. A. Adv. clin. Chem. 1972, 15, 255.
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Certainly, the changes which we have recorded in plasma
substrate and hormone concentrations could be due to
" 
severe psychological stress ", but to determine whether
they were initiated by the heart-attack itself or by the
psychological reaction to it or by the psychological reaction
to intensive care would be very difficult. A similar study
in the earliest hours of home care might resolve the last
possibility. It is our experience that anxiety occurring in a
coronary-care unit is not related to the severity of the
physical reaction to the attack,4 and yet in our study
many of the changes were. Therefore it seems unlikely
that psychological factors played a major part in altering
the plasma concentration of substrates and hormones.
As a point of further information, we have examined 15
patients with myocardial infarction within 30 minutes of
admission to the coronary-care unit and have measured
plasma-total-catecholamine concentrations, anxiety using
the Neuroticism Scale Questionnaire,&oacute; and clinical severity
measured by prognostic indices and serum-enzyme
changes. There was a close correlation between plasma-
total-catecholamines and severity (r=0-78, p< 0-001), but
no correlation between anxiety and either plasma-catechola-
mine concentrations or severity
Finally, Dr Pallor misses the purpose of our report,
which is to define and delineate the earliest changes in the
plasma concentrations of substrates and hormones so that
the response of the myocardium to ischaemia is better
understood and metabolic, therapeutic, or preventive







FOOD ANTIBODIES AND MYOCARDIAL
INFARCTION
SIR,-As babies, most of us had antibodies to milk which
could well return rapidly after the passage of traces of
milk protein through the lungs or across an inflamed
oesophagus. This might happen in patients who have
vomited a lot; who have lain long on their backs or been
fed in that position; or who have suffered cesophageal
reflux while shocked, sedated, or supine. Thus milk
antibodies are perhaps more likely to appear after a severe
than after a mild cardiac infarction. Could this be a factor
in their association with death, which Dr Davies and his
colleagues report (May 25, p. 1012), irrespective of any
response of the body to their formation ? It would be
interesting to know which of their controls drink heavily,
have hiatus hernias, or sleep on their backs.
The Warren,
Downton,
Wiltshire. T. H. HUGHES-DAVIES.
MOBILE CORONARY CARE
SIR,-In reply to Dr Webb’s interesting letter (March
30, p. 559), may I make the following comments ? Whilst it
is certainly true that the correction of ventricular fibrillation
is not the sole benefit of mobile coronary-care units, it is
the only available direct evidence of life-saving peculiar to
these units, and is therefore the most appropriate index by
which to compare them.
Secondly, Dr Webb’s estimate that the medically staffed
unit saved six times the number of lives that the Brighton
Ambulance Service did is almost certainly a gross exaggera-
tion, for he appears to assume that the 9% lower hospital
4. Cay, E. L., Vetter, N., Philip, A. E., Dugard, P. J. psychosom. Res.
1972, 16, 437.
5. Keer-Calwell, J. J. Br. J. soc. clin. Psych. 1965, 4, 214.
mortality of patients with myocardial infarction, seen within
three hours of the onset of symptoms, is due entirely to the
" medical " intervention of the mobile unit.
It is extremely unlikely that the whole of this 9%
difference in mortality derives from initiating therapy at
the beginning of the ambulance journey rather than at the
end. Would not some difference in mortality still have been
apparent even if medical therapy was deferred until
hospital was reached? Let us also not forget the contribu-
tion of the coronary-care unit to reducing mortality amongst
those patients who would have reached hospital before
three hours without the help of the mobile unit.
Furthermore, Dr Webb fails to mention that the Brighton
service would also have got a large number of myocardial-
infarct patients to hospital, and thereby specialised care,
within three hours. A reasonable estimate of this number
would be 300 cases annually (50% of the myocardial-
infarction cases seen), which, using his argument, would
mean that the Brighton service could also claim to have
prevented a further 27 deaths, giving a rate of 8-25 " lives
saved " per 100,000 population served-a figure very similar
to the Belfast estimate of 8-6.
On present evidence, therefore, it seems that, so far as the
contribution of the mobile units is concerned, a Belfast
domicile is no more advantageous than a Brighton one in
reducing mortality from myocardial infarction, and that
any disadvantage that might arise from not having a doctor
on the ambulance is balanced by the gaining of hospital
admission some 86 minutes earlier by using the 999 svstem.
Neuadd Meirionnydd,
Heath Park,
Cardiff. T. J. ORCHARD.
NOMENCLATURE AND ABBREVIATIONS
FOR VITAMIN D METABOLITES
SIR,-The most notable advance in our understanding
of the mechanism of action of the fat-soluble vitamin D
has been the elucidation of the complex structural modifica-
tions of the parent seco-steroid which are associated with the
metabolism to its biologically active form. 1 To date, at
least seven different hydroxylated modifications of chole-
calciferol (Ds) [25-OH-D3; 1,25-(OH)a-D3; 1,24,25-
(OH)s-Dg; 24,25-(OH)2,-D3: 25,26-(OH),-Ds] and
ergocalciferol (D2) [25-OH-D2 ; l,25-(OH)2-Dz] have been
chemically characterised. More recently, efforts have been
directed at synthesis of clinically useful analogues, such as
1-OH-Ds. Unfortunately, there is no agreement among
workers (who include chemists, biochemists, and clinicians)
as to what are acceptable and unambiguous abbreviations for
these compounds. Thus, in recent publications 25-hydroxy-
cholecalciferol has been abbreviated as 25-H.c.c.,4 25-H.C.C., &oacute;
25-OH-D35 25-OH-CGl while 1,25-dihydroxychole-
calciferol has been abbreviated as 1,25-DHCC,6 1,25-
D.H.C.C.,4 1,25-diOH-CC, 1,25-(OH)Q-CC,1 or 1,25-(OH)2-
D a.1 i In my opinion, there is no basis in the rules of
chemical nomenclature for abbreviating a hydroxyl with
an H or indicating the number of hydroxyls with capital
letters, such as a D for di, T for tri (or tetra ?), and so on.
Also, no obvious benefit accrues to the reader by insertion
of the plethora of periods as in 1,25-D.H.C.C. Many of these
notations undoubtedly were originally laboratory jargon.
But in view of the increasing number of these calciferol
metabolites and analogues, it is now appropriate to propose
1. Norman, A. W., Henry, H. Clin. Orthop&oelig;d. rel. Res. 1974, 98, 258.
2. Barton, D. H. R., Hesse, R. H., Pecket, M., Rizzardo, E. J. Am.
chem. Soc. 1973, 95, 2748.
3. Okamura, W. H., Mitra, M. N., Norman, A. W., Pirio, R., Sine,
S. M., Wing, R. M. Fedn Proc. 1974, 33, 1574
4. Kodicek, E. Lancet, March 2, 1974, p. 329.
5. Haddad, J. G., Hahn, T. J. Nature, 1973, 244, 515.
6. Frolik, C. A., DeLuca, H. F. Archs Biochem. Biophys. 1971, 147, 143.
